Search results (8261)
« Back to PublicationsCancer inequalities in the United Kingdom and the data used to measure them: a scoping review.
Underwood S. et al, (2025), Lancet Reg Health Eur, 52
Exercise Improves Myocardial Deformation But Not Cardiac Structure in Preterm-Born Adults: A Randomized Clinical Trial.
Lapidaire W. et al, (2025), JACC Adv, 4
The Contribution of Gametic Phase Disequilibrium to the Heritability of Complex Traits
CHEN Z. et al, (2025), Stroke
Association of Daily Steps with Incident Non-Alcoholic Fatty Liver Disease: Evidence from the UK Biobank Cohort.
Fulda ES. et al, (2025), Med Sci Sports Exerc
Hyperuricemia, gout and the associated comorbidities in China: findings from a prospective study of 0.5 million adults
CHEN Z. et al, (2025), The Lancet Regional Health - Western Pacific
Stroke risk management in carotid atherosclerotic disease: a clinical consensus statement of the ESC Council on Stroke and the ESC Working Group on Aorta and Peripheral Vascular Diseases.
Musialek P. et al, (2025), Cardiovasc Res, 121, 13 - 43
Treatment persistence and variations in prescribing oral, injectable, and inhaled corticosteroids: a population-based drug utilisation study
Domzaridou E. et al, (2025), Pharmacoepidemiology and Drug Safety
The research relationship: participant perspectives on consent in biobanking.
Thompson R. et al, (2025), BMC Med Ethics, 26
[Associations of plasma metabolites with mortality in Chinese adults: a prospective study].
Wu T. et al, (2025), Zhonghua Liu Xing Bing Xue Za Zhi, 46, 557 - 565
Prediabetes and risk of all-cause and cause-specific mortality: a prospective study of 114,062 adults in Mexico City.
Fermín-Martínez CA. et al, (2025), J Clin Endocrinol Metab
Translational genomics of osteoarthritis in 1,962,069 individuals.
Hatzikotoulas K. et al, (2025), Nature
Combined associations of physical activity, diet quality and their trajectories with incidence of diabetes and cardiovascular diseases in the EPIC-Norfolk Study.
Aryannezhad S. et al, (2025), Scientific reports, 15
Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.
Mayne KJ. et al, (2025), Nephrol Dial Transplant, 40, 720 - 730